ReviewEULAR rheumatology open2025
Five years of the Digital Rheumatology Network: insights and future directions.
Review in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structured prompting as reusable clinical tools.EULAR rheumatology open · 2026Article
- Healthcare professionals' perspectives on digital biomarkers for monitoring inflammatory arthritis: insights from a qualitative study rooted in design thinking.EULAR rheumatology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To outline Digital Rheumatology Network (DRN)'s activities, trends, and achievements over the past 5 years and to highlight concrete implementations and future directions in digital rheumatology. Methods: This article reviews the evolution of DRN activities, such as podcasts, webinars, research awards, start-up pitches, and the Digital Rheumatology Days (DRD) conference content including trends in the field. Results: The DRD conference has evolved from a 2019 in-person event to a hybrid format by 2021, with themes progressing from general eHealth to digital therapeutic programmes, remote patient monitoring, and various artificial intelligence (AI) applications such as for disease prediction, digital biomarkers, or large language models. Workshops on app development, coding, machine learning, large language models, and digital pathways have fostered multidisciplinary engagement. DRD participants include rheumatologists, nurses, patients, researchers, and industry or start-up representatives. Social media engagement, podcasts, and DRN's presence at European Alliance of Associations for Rheumatology (EULAR) and American College of Radiology (ACR) have expanded its reach. As a major achievement, DRN has fostered digital literacy among various stakeholders over the past years while also raising awareness and promoting cross-disciplinary collaborations. Key trends include the expansion and implementation of AI algorithms in clinical pathways, disease-specific remote monitoring, and digital therapeutic programmes, with a focus on evidence, adoption, and implementation in clinical practice. Conclusions: DRN has become a catalyst for digital health innovation in rheumatology, connecting medical knowledge and technical understanding, fostering collaboration, and thus driving the adoption of digital tools. Moving forward, DRN will continue to accompany digital transformation and promote digital literacy.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.